Further re Rule 2.11d disclosure

10th Dec 2010 14:26

Disclosure under Rule 2.11d of The Takeover Code

Aberforth Partners LLP ("Aberforth") provided a non-binding letter of intent to BTG plc regarding BTG plc's proposed acquisition of Biocompatibles International plc ("Biocompatibles"), as referred to in the announcement of the acquisition dated 19 November 2010. On 09 December 2010, Aberforth disposed of 40,057 shares (over which it had voting authority) in Biocompatibles, on behalf of clients. As a result, Aberforth now intends to vote in favour of the resolutions to be proposed at the Court Meeting and the Biocompatibles general meeting necessary to approve the Scheme (or as the case may be, to accept the Takeover Offer) in respect of 3,676,082 Biocompatibles shares, over which it has voting authority.

Date: 10 December 2010

Contact: Pauline Robson, for Aberforth Partners LLP

Telephone: 0131 220 0733

vendor

---

Related Shares:

BTG